BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, June 24, 2026
Home » Authors » Omar Ford

Omar Ford

Articles

ARTICLES

TSJ articles say Medtronic's Infuse studies show bias

July 5, 2011
By Omar Ford
Medtronic's (Minneapolis) Infuse bone graft application has been sharply criticized by a group of spine specialists who are repudiating the research of experts that have backed the widespread use of the product. (Medical Device Daily)
Read More

ALSCG paper shows med-tech's risks, benefits from ACO model

June 30, 2011
By Omar Ford

IBM study shows patients have high demand for wellness devices

June 29, 2011
By Omar Ford

Hamilton Thorne aims Lykos at clinical, fertility markets

June 28, 2011
By Omar Ford

BSD Medical's technology receives boost from study

June 27, 2011
By Omar Ford

It's official: Dentsply to acquire Astra Tech for $1.8 billion

June 23, 2011
By Omar Ford

Dime-sized implant could treat paralysis, epilepsy patients

June 20, 2011
By Omar Ford

World Micro sets sights on medical device market

June 17, 2011
By Omar Ford
With an emphasis on stringent quality measures, and steady growth, it was only a matter of time before World Micro (Atlanta) delved into the med-device sector. The electronics distributor, which is a private company and serves the military/aerospace sector, said earlier today that it was going to roll out a new business sector to serve the unique requirements of the medical device market. (Medical Device Daily)
Read More

Don't forget med-tech

June 16, 2011
By Omar Ford
Last week, the Advanced Medical Technology Association (AdvaMed; Washington) put on its Superman cape and unveiled a set of policy recommendations that it hopes will preserve America's position as a leader in medical technology innovation. Dubbed the Competitiveness Agenda (which can be seen in more detail by clicking here), AdvaMed is issuing out a call to arms to the government to not overlook the med-tech industry.  Here's the problem that the med-tech industry is facing. Imagine for one moment that you're on the brink of not being able to pay your mortgage. Slowly and steadily you're getting behind on the bills...
Read More

J&J, Cordis in shakeup; will scrap key DES lines

June 16, 2011
By Omar Ford
Cordis (Bridgewater, New Jersey), the stent making arm of Johnson & Johnson (J&J; New Brunswick, New Jersey), is pulling out of the drug-eluting stent (DES) business, as tougher competition and a flat market have eroded sales of these once top products. (Medical Device Daily)
Read More
View All Articles by Omar Ford

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 24, 2026.
  • Blue brain with computer chip

    Have brain-computer interfaces finally arrived?

    BioWorld
    More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 23, 2026
  • In the clinic for June 22, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
  • Photo of two people shaking hands near lab equipment

    K2 nabs two Antengene bispecific TCEs in $2B license, option deal

    BioWorld
    MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing